XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders’ Equity (Details Narrative) - USD ($)
12 Months Ended
Jun. 02, 2021
Sep. 28, 2020
Mar. 20, 2020
Dec. 31, 2021
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]          
Number of options to purchase common stock       58,113 82,258
Number of warrants issued to investors       10,550  
Stock Issued During Period, Value, New Issues       $ 6,000,000 $ 3,797,800
Debt Conversion, Converted Instrument, Amount     $ 437,201    
Convertible debt to common stock shares     366,925    
Debt retired amount       $ 840,000  
Warrants weighted average exercise price       $ 4.15  
Unrecognized share-based compensation expense       $ 148,398  
Unrecognized share-based compensation weighted average period       1 year 6 months  
General and Administrative Expense [Member]          
Subsidiary, Sale of Stock [Line Items]          
Share-based Payment Arrangement, Expense       $ 91,959 $ 276,641
2015 Plan [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of shares available for grants       435,750  
2015 Plan [Member] | Employees, Board of Directors and Other Service [Member]          
Subsidiary, Sale of Stock [Line Items]          
Common stock shares issued       1,153,846  
Minimum [Member]          
Subsidiary, Sale of Stock [Line Items]          
Warrant exercise price       $ 3.12  
Maximum [Member]          
Subsidiary, Sale of Stock [Line Items]          
Warrant exercise price       $ 9.10  
Share-based Payment Arrangement, Option [Member]          
Subsidiary, Sale of Stock [Line Items]          
Common stock shares issued         50,358
Stock Issued During Period, Value, New Issues         $ 392,789
Number of common stock issued for services       17,273 20,966
Share-based Payment Arrangement, Option [Member] | Minimum [Member]          
Subsidiary, Sale of Stock [Line Items]          
Stock issued price per share       $ 4.94 $ 3.25
Share-based Payment Arrangement, Option [Member] | Maximum [Member]          
Subsidiary, Sale of Stock [Line Items]          
Stock issued price per share       10.15 6.50
Executive Deferred Compensation [Member]          
Subsidiary, Sale of Stock [Line Items]          
Warrant exercise price         $ 3.51
Executive deferred compensation payments with the issuance of warrants         121,076
Fair value of warrants         $ 251,837
Stock based compensation         $ 83,945
Warrant [Member]          
Subsidiary, Sale of Stock [Line Items]          
Warrants weighted average exercise price       7.49  
Warrant [Member] | Minimum [Member]          
Subsidiary, Sale of Stock [Line Items]          
Warrant exercise price       3.25  
Warrant [Member] | Maximum [Member]          
Subsidiary, Sale of Stock [Line Items]          
Warrant exercise price       $ 5.46  
Private Placement [Member]          
Subsidiary, Sale of Stock [Line Items]          
Stock issued price per share $ 4.68       $ 6.50
Gross proceeds from private placement $ 6,000,000       $ 3,825,000
Number of options to purchase common stock         588,462
Warrant exercise price   $ 5.85      
Debt conversion, description         If the volume-weighted average trading price for the 20 consecutive trading days that conclude upon 6 months after the initial closing (the “Six Month Price”) exceeds or equals $6.50 per share (the “Target Price”), the per share purchase price will not be adjusted. If the Six Month Price is less than the Target Price, the per share purchase price will be automatically reduced to the Six Month Price, but in no event less than $4.55 per share, in which case the Company shall issue to each investor, pro-rata based on such investor’s investment: (a) shares in a quantity that equals the difference between the number of shares issued to such purchaser at closing and the number of shares that would have been issued to such purchaser at closing at the Six Month Price; and (b) a warrant for 0.50 shares for each additional share issued, with an exercise price equal to the sum of $1.30 per share and the Six Month Price, but in no event less than $5.85 per share.
Common stock shares issued 1,282,051 409,451      
Number of warrants issued to investors   204,726      
Shares issued during the period, conversion of convertible securities         366,925
Number of warrants issued on debt conversion         35,308
Debt Conversion, Converted Instrument, Amount       $ 399,000  
Interest on debt       $ 234,410  
Convertible debt to common stock shares       133,991  
Private Placement [Member] | Warrant O [Member]          
Subsidiary, Sale of Stock [Line Items]          
Number of options to purchase common stock         294,231
Stock option exercisable term         3 years
Warrant exercise price         $ 7.80